An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome

This narrative review reports on the pharmacological and pharmacokinetic properties of rotigotine, a non-ergolinic D(3)/D(2)/D(1) dopamine receptor agonist approved for the treatment of early- and advanced-stage Parkinson’s disease (PD) and moderate to severe restless legs syndrome (RLS). Rotigotine...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drugs
Autores principales: Elshoff, Jan-Peer, Cawello, Willi, Andreas, Jens-Otto, Mathy, Francois-Xavier, Braun, Marina
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2015
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382528/
https://ncbi.nlm.nih.gov/pubmed/25795100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-015-0377-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares